Nephroprotective strategies in septic shock: the VANISH trial
Commentary
Nephroprotective strategies in septic shock: the VANISH trial
Sophia Kwon, George Crowley, Syed Hissam Haider, Liqun Zhang, Anna Nolan
Abstract
In the August issue of JAMA, Gordon and colleagues compared the outcomes of renal failure in septic shock between early vasopressin and norepinephrine treatment (1).
